Rubius Therapeutics Raises $100 Million in Crossover Financing Post author:Sam Post published:February 28, 2018 Post category:BioPharma Rubius Therapeutics has closed on an oversubscribed $100 million crossover financing. Source: BioSpace You Might Also Like ICON Reports Fourth Quarter And Full Year 2016 Results February 15, 2017 Takeda's Partner Merges With Crestovo to Form Finch Therapeutics Group October 22, 2017 Former PTC Therapeutics Exec Jumps Ship to Orchard Therapeutics as CEO August 9, 2017